2024 ICD-10-CM Diagnosis Code Q85.81

PTEN hamartoma tumor syndrome

  • Q85.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • ICD-10-CM Q85.81 is a revised 2024 ICD-10-CM code that became effective on October 1, 2023.
  • This is the American ICD-10-CM version of Q85.81 – other international versions of ICD-10 Q85.81 may differ.

Applicable To

  • PHTS
  • PTEN related Cowden syndrome

Code Also

  • , if applicable, genetic susceptibility to malignant neoplasm (Z15.0-)

The following code(s) above Q85.81 contain annotation back-references

 that may be applicable to Q85.81:

  • Q00-Q99  Congenital malformations, deformations and chromosomal abnormalities
  • Q85  Phakomatoses, not elsewhere classified
  • Q85.8  Other phakomatoses, not elsewhere classified

Present On Admission

  • Q85.81 is considered exempt from POA reporting.

ICD-10-CM Q85.81 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
  • 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
  • 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
  • 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
  • 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
  • 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
  • 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
  • 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Code History

  • 2023 (effective 10/1/2022): New code
  • 2024 (effective 10/1/2023): Revised code
    • New description: PTEN hamartoma tumor syndrome
    • 2023 description: PTEN tumor syndrome

Diagnosis Index entries containing back-references to Q85.81: